Allucent unveils IGNITE network for clinical trials

Allucent has introduced the IGNITE aimed at improving speed, quality as well as predictability across clinical trial delivery. The IGNITE network connects trial sponsors with research sites aligned to Allucent’s therapeutic centres of expertise. IGNITE offers sponsors feasibility assessments within 72 hours and access to pre-qualified sites. Credit: SmartPhotoLab/Shutterstock.com. Allucent has introduced the Integrated Global Network for Innovative Trial Execution (IGNITE) aimed at improving speed, quality as well as predictability across clinical trial delivery. The network encompasses over 250 pre-qualified clinical research sites and is intended to facilitate faster site activation, improved patient recruitment, and reduced risk in the development…

Source: Clinical Trials Arena